Quest Diagnostics Incorporated: The world's leader in diagnostic testing, information, services, blood tests, and lab tests.

The world’s leader in diagnostic
testing, information, and services

Lab & Healthcare Services

Find a Quest Diagnostics Location Make an Appointment Confirm / Change / Cancel Appt Get My Results Diagnostic Services Health Plan Services Patient Health Library Health Reminder Emails Employer Solutions Health & Wellness Programs International Locations Hospital Services Test Menu

Featured Lab Tests

All Featured Lab Tests Cardio CRP® ImmunoCAP® Specific IgE Blood Test Leumeta™ Cancer Tests

Online Services

Pay Your Bill Update Insurance Information Order Tests & View Results

Medical Research

Clinical Trials Nichols Institute

Vitamin D Testing

Get the facts here

2009 H1N1 influenza virus

Learn more

En Español


			Careers Press Releases Newsroom Investor Relations Privacy Policy Site Directory Terms & Conditions

Physicians: Get your CMS E-Prescribing incentive payment! Our Care360™ Labs & Meds with ePrescribing meets the requirements for a qualified E-Prescribing system.

Physicians: ePrescribing can help you qualify for the CMS 2% incentive payment. Now with our limited time offer, you can try ePrescribing for 6 months — and if it doesn't meet your needs, cancel and pay no monthly fees.

Use our Drug Testing Return on Investment Calculator to learn how much money your company can save with a drug testing program through Quest Diagnostics.

H1N1

Physicians and patients: Learn about testing options for the 2009 H1N1 Influenza Virus.

Read the latest Quest Diagnostics Health Trends™ Report about the behavior of the 2009 H1N1 flu virus, based on our testing data.

Watch the video "Beat the Disease to the Market" to learn Quest Diagnostics' approach to developing diagnostics for infectious diseases.

Physicians: Empower your patients to get their results online and take a more active role in their health.
Patients: Get your lab results online with: Google Health™, Keas™, MicroSoft®, HealthVault™ or Quest Diagnostics’ MyCare360.

We offer several programs to assist patients facing financial difficulty, including our Financial Assistance Program, free or reduced fee laboratory services, and our participation in the Take Care Recovery Plan.

End of H1N1 "Second Wave" in Sight in the U.S., According to Quest Diagnostics

-	Quest Diagnostics Health Trends™ Report shows 75 percent decline in rates of 2009 H1N1 influenza virus testing, but H1N1 is still the predominant influenza strain infecting Americans

Quest Diagnostics Reveals New Genetic Discoveries for Testing for Leukemia, Lymphoma and Blood Clotting at 51st ASH Meeting and Exposition

-	Research to expand Leumeta™ line of blood plasma diagnostics; Scientists also describe technique for predicting response to Heparin surrogate

H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics

-	Quest Diagnostics Health Trends™ Report based on results of more than 142,000 patient specimens tested for 2009 H1N1 influenza virus since May 2009

New Hair Data Validate Sharp Downward Trend in Cocaine and Methamphetamine Positivity in General U.S. Workforce, According to Quest Diagnostics Drug Testing Index™

-	Hair data reveal higher use for certain drugs than urine data alone reflect
-	First large-scale analysis of same-donor hair and urine specimens draws useful distinctions between test methods

2009 H1N1 Flu Test from Quest Diagnostics Now CE Marked For International Distribution under the Simplexa™ brand name

-	Simplexa™ molecular RT-PCR test runs on the 3M Integrated Cycler; employs RT-PCR technologies comparable to 2009 H1N1 flu test used by World Health Organization